{"context":{"query":">>efo>>gwas_study","source_dataset":"efo","target_dataset":"gwas_study"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]EFO:0003888,72,EFO:0003888,165,0]["},"schema":"id|disease_trait|first_author|journal|publication_date","mappings":[{"input":"EFO:0003888","source":"EFO:0003888|attention deficit hyperactivity disorder","targets":["GCST000235|Attention deficit hyperactivity disorder|Mick E|Am J Med Genet B Neuropsychiatr Genet|2008-09-26","GCST000246|Attention deficit hyperactivity disorder|Lesch KP|J Neural Transm (Vienna)|2008-10-07","GCST000247|Attention deficit hyperactivity disorder symptoms (maternal expressed emotions interaction)|Sonuga-Barke EJ|Am J Med Genet B Neuropsychiatr Genet|2008-10-07","GCST000253|Attention deficit hyperactivity disorder and conduct disorder|Anney RJ|Am J Med Genet B Neuropsychiatr Genet|2008-10-24","GCST000259|Attention deficit hyperactivity disorder|Neale BM|Am J Med Genet B Neuropsychiatr Genet|2008-11-03","GCST000280|Attention deficit hyperactivity disorder (time to onset)|Lasky-Su J|Am J Med Genet B Neuropsychiatr Genet|2008-12-05","GCST000281|Attention deficit hyperactivity disorder|Lasky-Su J|Am J Med Genet B Neuropsychiatr Genet|2008-12-05","GCST000684|Attention deficit hyperactivity disorder|Mick E|J Am Acad Child Adolesc Psychiatry|2010-05-14","GCST000751|Attention deficit hyperactivity disorder|Neale BM|J Am Acad Child Adolesc Psychiatry|2010-08-01","GCST000757|Attention deficit hyperactivity disorder|Neale BM|J Am Acad Child Adolesc Psychiatry|2010-08-05","GCST001030|Attention deficit hyperactivity disorder motor coordination|Fliers EA|World J Biol Psychiatry|2011-04-07","GCST001154|Attention deficit hyperactivity disorder|Mick E|J Am Acad Child Adolesc Psychiatry|2011-07-13","GCST001287|Attention deficit hyperactivity disorder|Hinney A|Am J Med Genet B Neuropsychiatr Genet|2011-10-19","GCST001395|Attention deficit hyperactivity disorder|Stergiakouli E|Am J Psychiatry|2012-02-01","GCST001877|Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)|Smoller JW|Lancet|2013-02-27","GCST001931|Attention deficit hyperactivity disorder (combined symptoms)|Ebejer JL|Twin Res Hum Genet|2013-04-01","GCST001943|Attention deficit hyperactivity disorder (inattention symptoms)|Ebejer JL|Twin Res Hum Genet|2013-04-01","GCST001944|Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)|Ebejer JL|Twin Res Hum Genet|2013-04-01","GCST002048|Attention deficit hyperactivity disorder|Yang L|Am J Med Genet B Neuropsychiatr Genet|2013-05-31","GCST002648|Persistent attention-deficit hyperactivity disorder|Sanchez-Mora C|Neuropsychopharmacology|2014-10-06","GCST002848|Attention deficit hyperactivity disorder|Zayats T|PLoS One|2015-04-13","GCST004001|Bipolar disorder or attention deficit hyperactivity disorder|van Hulzen KJE|Biol Psychiatry|2016-10-18","GCST004002|Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder|van Hulzen KJE|Biol Psychiatry|2016-10-18","GCST004223|Attention deficit hyperactivity disorder and obsessive compulsive disorder|Ritter ML|Front Mol Neurosci|2017-03-23","GCST004778|Attention deficit hyperactivity disorder|Liu L|Transl Psychiatry|2017-08-15","GCST005361|Attention deficit hyperactivity disorder (sex interaction)|Martin J|Biol Psychiatry|2017-12-02","GCST005362|Attention deficit hyperactivity disorder|Martin J|Biol Psychiatry|2017-12-02","GCST006216|Attention deficit hyperactivity disorder or educational attainment (years of education) (pleiotropy)|Shadrin AA|J Am Acad Child Adolesc Psychiatry|2017-11-26","GCST006668|Psychiatric diseases (pleiotropy) (HIPO component 1)|Qi G|PLoS Genet|2018-10-05","GCST006916|Attention deficit hyperactivity disorder|Hawi Z|Transl Psychiatry|2018-12-18","GCST006983|Attention deficit hyperactivity disorder or cannabis use|Soler Artigas M|Mol Psychiatry|2019-01-04","GCST007543|Attention deficit hyperactivity disorder|Demontis D|Nat Genet|2018-11-26","GCST007582|Attention deficit hyperactivity disorder or putamen volume (pleiotropy)|Klein M|Am J Psychiatry|2019-03-01","GCST007583|Attention deficit hyperactivity disorder or nucleus accumbens volume (pleiotropy)|Klein M|Am J Psychiatry|2019-03-01","GCST007584|Attention deficit hyperactivity disorder or thalamus volume (pleiotropy)|Klein M|Am J Psychiatry|2019-03-01","GCST007585|Attention deficit hyperactivity disorder or pallidum volume (pleiotropy)|Klein M|Am J Psychiatry|2019-03-01","GCST007586|Attention deficit hyperactivity disorder or intracranial volume (pleiotropy)|Klein M|Am J Psychiatry|2019-03-01","GCST007587|Attention deficit hyperactivity disorder or hippocampal volume (pleiotropy)|Klein M|Am J Psychiatry|2019-03-01","GCST007588|Attention deficit hyperactivity disorder or amygdala volume (pleiotropy)|Klein M|Am J Psychiatry|2019-03-01","GCST007591|Attention deficit hyperactivity disorder or caudate nucleus volume (pleiotropy)|Klein M|Am J Psychiatry|2019-03-01","GCST007777|Mental disorder|Schork AJ|Nat Neurosci|2019-01-28","GCST008416|Psychiatric disorder without cannabis use disorder|Demontis D|Nat Neurosci|2019-06-17","GCST008417|Mental disorder|Demontis D|Nat Neurosci|2019-06-17","GCST008919|Asthma and attention deficit hyperactivity disorder|Zhu Z|Eur Respir J|2019-10-17","GCST009600|Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)|Cross-Disorder Group of the Psychiatric Genomics Consortium|Cell|2019-12-01","GCST010218|Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)|Kweon K|Soa Chongsonyon Chongsin Uihak|2018-04-01","GCST010219|Attention deficit hyperactivity disorder (inattention symptoms)|Kweon K|Soa Chongsonyon Chongsin Uihak|2018-04-01","GCST010220|Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)|Kweon K|Soa Chongsonyon Chongsin Uihak|2018-04-01","GCST010221|Attention deficit hyperactivity disorder (inattention symptoms)|Kweon K|Soa Chongsonyon Chongsin Uihak|2018-04-01","GCST010222|Attention deficit hyperactivity disorder|Kweon K|Soa Chongsonyon Chongsin Uihak|2018-04-01","GCST010289|Attention deficit hyperactivity disorder (childhood)|Rovira P|Neuropsychopharmacology|2020-04-12","GCST010290|Attention deficit hyperactivity disorder (persistent)|Rovira P|Neuropsychopharmacology|2020-04-12","GCST010291|Attention deficit hyperactivity disorder|Rovira P|Neuropsychopharmacology|2020-04-12","GCST010644|Attention deficit hyperactivity disorder (MTAG)|Wu Y|Transl Psychiatry|2020-06-30","GCST010649|Attention deficit hyperactivity disorder|Wu Y|Transl Psychiatry|2020-06-30","GCST012088|Neuropsychiatric disorders|Yao X|Transl Psychiatry|2021-01-21","GCST012093|Attention deficit hyperactivity disorder (MTAG)|Yao X|Transl Psychiatry|2021-01-21","GCST012096|Attention deficit hyperactivity disorder|Demontis D|Nat Commun|2021-01-25","GCST012098|Disruptive behavior disorder and attention deficit hyperactivity disorder|Demontis D|Nat Commun|2021-01-25","GCST012597|Attention deficit hyperactivity disorder|Martin J|Biol Psychiatry|2017-12-02","GCST012957|Attention deficit hyperactivity disorder, intelligence or educational attainment (pleiotropy)|O'Connell KS|Biol Psychiatry|2019-11-29","GCST90016595|ADHD vs anorexia nervosa (ordinary least squares (OLS))|Peyrot WJ|Nat Genet|2021-03-08","GCST90016596|ADHD vs autism spectrum disorder (ordinary least squares (OLS))|Peyrot WJ|Nat Genet|2021-03-08","GCST90016597|ADHD vs obsessive compulsive disorder (ordinary least squares (OLS))|Peyrot WJ|Nat Genet|2021-03-08","GCST90016598|ADHD vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS))|Peyrot WJ|Nat Genet|2021-03-08","GCST90016604|Bipolar disorder vs ADHD (ordinary least squares (OLS))|Peyrot WJ|Nat Genet|2021-03-08","GCST90016612|Major depressive disorder vs ADHD (ordinary least squares (OLS))|Peyrot WJ|Nat Genet|2021-03-08","GCST90016618|Schizophrenia vs ADHD (ordinary least squares (OLS))|Peyrot WJ|Nat Genet|2021-03-08","GCST90061435|Externalizing behaviour (multivariate analysis)|Karlsson Linner R|Nat Neurosci|2021-08-26","GCST90133365|Attention deficit hyperactivity disorder or autism spectrum disorder (pleiotropy)|Baranova A|Psychiatry Res|2022-06-13","GCST90134330|Attention deficit hyperactivity disorder or autism spectrum disorder or intelligence (pleiotropy)|Rao S|Neuropsychobiology|2022-06-28","GCST90137499|Attention deficit hyperactivity disorder (childhood)|Rajagopal VM|Nat Genet|2022-08-04","GCST90137500|Attention deficit hyperactivity disorder (persistent)|Rajagopal VM|Nat Genet|2022-08-04","GCST90137501|Attention deficit hyperactivity disorder (late-diagnosed)|Rajagopal VM|Nat Genet|2022-08-04","GCST90269774|Attention deficit hyperactivity disorder|Demontis D|Nat Genet|2023-01-26","GCST90271328|Irritable bowel syndrome or attention-deficit/hyperactivity disorder (pleiotropy)|Gong W|JAMA Psychiatry|2023-02-08","GCST90271334|Peptic ulcer disease or attention-deficit/hyperactivity disorder (pleiotropy)|Gong W|JAMA Psychiatry|2023-02-08","GCST90271340|Gastroesophageal reflux disease or attention-deficit/hyperactivity disorder (pleiotropy)|Gong W|JAMA Psychiatry|2023-02-08","GCST90275135|Attention deficit hyperactivity disorder (ADuLT model adjusted for age, sex)|Pedersen EM|Nat Commun|2023-09-09","GCST90275136|Attention deficit hyperactivity disorder (ADuLT model adjusted for sex)|Pedersen EM|Nat Commun|2023-09-09","GCST90275137|Attention deficit hyperactivity disorder (ADuLT model)|Pedersen EM|Nat Commun|2023-09-09","GCST90275147|Attention deficit hyperactivity disorder (adjusted for age, sex)|Pedersen EM|Nat Commun|2023-09-09","GCST90275148|Attention deficit hyperactivity disorder (adjusted for sex)|Pedersen EM|Nat Commun|2023-09-09","GCST90275149|Attention deficit hyperactivity disorder|Pedersen EM|Nat Commun|2023-09-09","GCST90275159|Attention deficit hyperactivity disorder (SPACox model adjusted for age, sex)|Pedersen EM|Nat Commun|2023-09-09","GCST90275160|Attention deficit hyperactivity disorder (SPACox model adjusted for sex)|Pedersen EM|Nat Commun|2023-09-09","GCST90277997|Attention deficit hyperactivity disorder|Chang X|Biol Psychiatry|2023-10-21","GCST90429151|Attention deficit hyperactivity disorder or risk-taking behavior (pleiotropy)|Chen Y|J Affect Disord|2024-03-31","GCST90448546|Attention deficit hyperactivity disorder (first diagnosed in adulthood vs childhood)|LaBianca S|Nat Genet|2023-11-30","GCST90448547|Attention deficit hyperactivity disorder|LaBianca S|Nat Genet|2023-11-30","GCST90448550|Attention deficit hyperactivity disorder first diagnosed in adulthood|LaBianca S|Nat Genet|2023-11-30","GCST90448551|Attention deficit hyperactivity disorder or Substance use disorder (pleiotropy)|LaBianca S|Nat Genet|2023-11-30","GCST90448552|Attention deficit hyperactivity disorder or autism spectrum disorder (pleiotropy)|LaBianca S|Nat Genet|2023-11-30","GCST90448553|Attention deficit hyperactivity disorder and Substance use disorder|LaBianca S|Nat Genet|2023-11-30","GCST90448554|Attention deficit hyperactivity disorder and Autism spectrum disorder|LaBianca S|Nat Genet|2023-11-30","GCST90455642|Education attainment or attention deficit hyperactivity disorder|Chen D|Front Psychiatry|2024-01-04","GCST90480762|Attention deficit hyperactivity disorder (PheCode 313.1)|Verma A|Science|2024-07-19","GCST90481834|Attention deficit hyperactivity disorder (PheCode 313.1)|Verma A|Science|2024-07-19","GCST90481835|Attention deficit hyperactivity disorder (PheCode 313.1)|Verma A|Science|2024-07-19","GCST90481836|Attention deficit hyperactivity disorder (PheCode 313.1)|Verma A|Science|2024-07-19"]}]}